Utah Admin. Code 156-17b-621a

Current through Bulletin 2024-23, December 1, 2024
Section R156-17b-621a - Operating Standards - Pharmacist Administration of a Long-acting Injectable and Naloxone - Training

In accordance with Subsections 58-17b-502(1)(i) and 58-17b-625(2):

(1) Prior to engaging in the administration of a long-acting injectable drug pursuant to Section 58-17b-625, a pharmacist shall successfully complete:
(a) current Basic Life Support (BLS) certification; and
(b) a training program for administering long-acting injectables intramuscularly that is provided by an ACPE-accredited provider.
(2) An individual who engages in the administration of long-acting injectable drugs intramuscularly shall maintain documentation that they obtained their required training.

Utah Admin. Code R156-17b-621a

Adopted by Utah State Bulletin Number 2018-1, effective 12/12/2017
Amended by Utah State Bulletin Number 2019-24, effective 11/25/2019
Amended by Utah State Bulletin Number 2022-03, effective 1/27/2022